|
Name |
2-(2-Hydroxy-5-methoxyphenyl)-4-methoxyphenol
|
Molecular Formula | C14H14O4 | |
IUPAC Name* |
2-(2-hydroxy-5-methoxyphenyl)-4-methoxyphenol
|
|
SMILES |
COC1=CC(=C(C=C1)O)C2=C(C=CC(=C2)OC)O
|
|
InChI |
InChI=1S/C14H14O4/c1-17-9-3-5-13(15)11(7-9)12-8-10(18-2)4-6-14(12)16/h3-8,15-16H,1-2H3
|
|
InChIKey |
ZOTPRNGZOCVFQN-UHFFFAOYSA-N
|
|
Synonyms |
2,2'-Bi(4-methoxyphenol); SCHEMBL8440252; 5,5'-dimethoxybiphenyl-2,2'-diol; 5,5'-dimethoxy-2,2'-dihydroxybiphenyl; 5,5'-dimethoxy[1,1'-biphenyl]-2,2'-diol; 2-(2-hydroxy-5-methoxyphenyl)-4-methoxyphenol; 2,2'-dihydroxy-5,5'-dimethyoxy-1,1'-biphenyl; 2,2'-Dihydroxyl-5,5'-dimethoxy-1,1'-biphenyl
|
|
CAS | NA | |
PubChem CID | 10014791 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 246.26 | ALogp: | 2.8 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 58.9 | Aromatic Rings: | 2 |
Heavy Atoms: | 18 | QED Weighted: | 0.869 |
Caco-2 Permeability: | -4.695 | MDCK Permeability: | 0.00001750 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.011 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.022 |
30% Bioavailability (F30%): | 0.192 |
Blood-Brain-Barrier Penetration (BBB): | 0.113 | Plasma Protein Binding (PPB): | 98.86% |
Volume Distribution (VD): | 0.576 | Fu: | 1.72% |
CYP1A2-inhibitor: | 0.961 | CYP1A2-substrate: | 0.954 |
CYP2C19-inhibitor: | 0.841 | CYP2C19-substrate: | 0.177 |
CYP2C9-inhibitor: | 0.567 | CYP2C9-substrate: | 0.953 |
CYP2D6-inhibitor: | 0.894 | CYP2D6-substrate: | 0.945 |
CYP3A4-inhibitor: | 0.752 | CYP3A4-substrate: | 0.329 |
Clearance (CL): | 11.832 | Half-life (T1/2): | 0.641 |
hERG Blockers: | 0.036 | Human Hepatotoxicity (H-HT): | 0.076 |
Drug-inuced Liver Injury (DILI): | 0.717 | AMES Toxicity: | 0.569 |
Rat Oral Acute Toxicity: | 0.095 | Maximum Recommended Daily Dose: | 0.214 |
Skin Sensitization: | 0.856 | Carcinogencity: | 0.12 |
Eye Corrosion: | 0.383 | Eye Irritation: | 0.976 |
Respiratory Toxicity: | 0.606 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004820 | 0.429 | D0DJ1B | 0.366 | ||||
ENC002205 | 0.402 | D05CKR | 0.342 | ||||
ENC002759 | 0.395 | D0U3YB | 0.341 | ||||
ENC005040 | 0.393 | D04KJO | 0.333 | ||||
ENC003034 | 0.391 | D0D1DI | 0.333 | ||||
ENC005039 | 0.386 | D0Q1IT | 0.333 | ||||
ENC002952 | 0.385 | D09WKB | 0.333 | ||||
ENC005870 | 0.382 | D09GYT | 0.324 | ||||
ENC005871 | 0.382 | D08LFZ | 0.320 | ||||
ENC006073 | 0.380 | D00KRE | 0.310 |